APA aipamena

Tanaka, R., Tomosugi, M., Horinaka, M., Sowa, Y., & Sakai, T. (2015). Metformin Causes G1-Phase Arrest via Down-Regulation of MiR-221 and Enhances TRAIL Sensitivity through DR5 Up-Regulation in Pancreatic Cancer Cells. Public Library of Science (PLoS).

Chicago Style aipamena

Tanaka, Ryoichi, Mitsuhiro Tomosugi, Mano Horinaka, Yoshihiro Sowa, and Toshiyuki Sakai. Metformin Causes G1-Phase Arrest via Down-Regulation of MiR-221 and Enhances TRAIL Sensitivity Through DR5 Up-Regulation in Pancreatic Cancer Cells. Public Library of Science (PLoS), 2015.

MLA aipamena

Tanaka, Ryoichi, et al. Metformin Causes G1-Phase Arrest via Down-Regulation of MiR-221 and Enhances TRAIL Sensitivity Through DR5 Up-Regulation in Pancreatic Cancer Cells. Public Library of Science (PLoS), 2015.